DZ Bank Call 16 VAR 20.06.2025/ DE000DJ5AQP8 /
10/06/2024 08:27:46 | Var.-0.030 | Denaro22:00:42 | Lettera22:00:42 | Sottostante | Prezzo di esercizio | Expiration date | Tipo di opzione |
---|---|---|---|---|---|---|---|
0.340EUR | -8.11% | - Quantità in denaro: - |
- Quantità in lettera: - |
VARTA AG O.N. | 16.00 EUR | 20/06/2025 | Call |
GlobeNewswire
00:13
ROSEN, SKILLED INVESTOR COUNSEL, Encourages GoodRx Holdings, Inc. Investors to Secure Counsel Before...
GlobeNewswire
00:00
GICAI launches revolutionary global digital currency quantitative trading platform to improve invest...
GlobeNewswire
10/06
Empower Healthcare Solutions and DispatchHealth® collaborate to bring in-home urgent medical care to...
GlobeNewswire
10/06
GENFIT: Historic Milestone Achieved with U.S. FDA Accelerated Approval of Ipsen’s Iqirvo® for Primar...
GlobeNewswire
10/06
Atour Lifestyle Holdings Limited Announces Proposed Registered Secondary Offering of American Deposi...
GlobeNewswire
10/06
ROSEN, LEADING TRIAL ATTORNEYS, Encourages Hertz Global Holdings, Inc. Investors to Secure Counsel B...
GlobeNewswire
10/06
LifeWallet’s Proprietary Data System is Instrumental in Class Certification Against USAA Property an...
GlobeNewswire
10/06
Bitfarms Announces Toronto Stock Exchange Deferral of Consideration of Shareholder Rights Plan
GlobeNewswire
10/06
Nova Vision Acquisition Corp. Announces Additional Contribution to Trust Account to Extend Period to...
GlobeNewswire
10/06
Inception Growth Acquisition Limited Announces Extension of Business Combination Period and Addition...
GlobeNewswire
10/06
CANON UNVEILS THE FUTURE OF EVERYDAY VR CONTENT CREATION WITH NEW DUAL FISHEYE LENS
GlobeNewswire
10/06
Ipsen’s Iqirvo® receives U.S. FDA accelerated approval as a first-in-class PPAR treatment for primar...
GlobeNewswire
10/06
CINT LOSS ALERT: ROSEN, A HIGHLY RECOGNIZED LAW FIRM, Encourages CI&T Inc Investors to Inquire About...